gdc

Immunotherapy

Keytruda Immunotherapy Prolongs Survival in Patients with Relapsed or Refractory Hodgkin Lymphoma
ImmunotherapyLymphoma
This article discusses findings from a clinical trial showing that Keytruda prolongs the time without disease progression in patients with relapsed or refractory classical Hodgkin lymphoma compared with the current standard of therapy.
Tecentriq plus Avastin First Immunotherapy Combination Approved as First-Line Treatment of Advanced Liver Cancer
FDA Approvals, News & UpdatesLiver CancerImmunotherapy
In May 2020, the FDA approved the combination of 2 immunotherapies for patients with metastatic hepatocellular carcinoma (liver cancer) who have not received systemic therapy and cannot be treated by surgery.
Immunotherapy with Opdivo Approved for Advanced Esophageal Cancer
Esophageal CancerFDA Approvals, News & UpdatesImmunotherapy
In June 2020, the FDA approved a new indication for Opdivo, a PD-1 inhibitor, for the treatment of patients with unresectable advanced, recurrent, or metastatic esophageal squamous-cell carcinoma, after the use of chemotherapy.
What Can You Expect with Cancer Immunotherapy?
Immunotherapy
Immunotherapy is offering exciting new treatments for many types of cancer. It works by revving up the immune system and can have various side effects in different patients.
A Breakthrough in the Treatment of Metastatic Triple-Negative Breast Cancer
Breast CancerImmunotherapy
Recently, Tecentriq became the first immunotherapy to be approved for the treatment of patients with metastatic triple-negative breast cancer, a particularly difficult type of breast cancer.
Keytruda plus Chemotherapy in Triple-Negative Breast Cancer
Breast CancerImmunotherapy
Triple-negative breast cancer is an aggressive type of cancer that usually has a high rate of disease recurrence (returning) within the first 5 years after diagnosis.
Why Target the Immune System?
Immunotherapy
The immune system attacks foreign substances by making large numbers of antibodies. These are proteins that attach to a specific protein on the cell called an antigen.
Page 2 of 6
Results 11 - 20 of 57

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country